XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer
Peking Union Medical College Hospital
Peking Union Medical College Hospital
IMGT Co., Ltd.
Medical College of Wisconsin
Arab American University (Palestine)
Peking Union Medical College Hospital
Cancer Research Antwerp
Guangzhou University of Traditional Chinese Medicine
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Karolinska University Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gansu Wuwei Tumor Hospital
University Hospital Tuebingen
Anhui Provincial Hospital
Ruijin Hospital
Oslo University Hospital
Fudan University
Sunnybrook Health Sciences Centre
The First Affiliated Hospital with Nanjing Medical University
Zhejiang Cancer Hospital
The First Affiliated Hospital with Nanjing Medical University
Xijing Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Harbin Medical University
Xijing Hospital
The First Affiliated Hospital of Soochow University
Dana-Farber Cancer Institute
Second Affiliated Hospital, School of Medicine, Zhejiang University
Zhejiang Cancer Hospital
Sun Yat-sen University
Azienda Ospedaliera di Padova
Chinese PLA General Hospital
Chung-Ang University
UNICANCER
Institut Cancerologie de l'Ouest
King Faisal Specialist Hospital & Research Center
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Roma La Sapienza
The Second Hospital of Shandong University
CHU de Reims
University of Florida
University of Florida
Alliance for Clinical Trials in Oncology
MyGenostics Inc., Beijing
Memorial Sloan Kettering Cancer Center
King Faisal Specialist Hospital & Research Center
Vrinnevi Hospital